植込み型医療機器の市場規模、シェア、動向分析レポート：製品別、生体材料別、最終用途別、地域別、セグメント予測、2024年～2030年

植込み型医療機器の市場動向

植込み型医療機器の世界市場規模は、2023年には915億米ドルと予測され、技術の進歩、慢性疾患の有病率の増加、低侵襲外科手術の需要拡大により、2024～2030年にかけてCAGR 6.1%で成長すると予測されています。手術技術、特に低侵襲手術の進歩により、植込み型医療機器の用途が拡大しています。例えば、2024年1月、米国の医療技術企業Accelusは、脊椎インプラント手術用のモジュラー式皮質システムを発表しました。このシステムは、外科医が早期にスクリューシャンクを配置し、コンストラクトをカスタマイズすることを可能にします。このシステムには、オープンと皮質のセットがあり、異なる手術アプローチに対応しています。

技術革新は市場成長の推進に極めて重要な役割を果たしています。材料科学、小型化、生体適合性、センサー技術の進歩は、植込み型器具の設計と機能に革命をもたらしました。例えば、チタン合金や生体吸収性ポリマーなどの先端生体材料の開発により、インプラントの耐久性、生体適合性、体内への統合性が向上しています。これらの材料は拒絶反応のリスクを減らし、組織の再生を促進し、患者の長期的な転帰を改善します。

さらに、センサー技術とワイヤレス接続性により、植込み型デバイスが生理学的パラメータのリアルタイムデータを収集し、この情報を医療提供者に遠隔送信することが可能になりました。この機能は、遠隔モニタリング、合併症の早期発見、タイムリーな介入をサポートします。例えば、植込み型心臓モニターは、心臓のリズムを継続的にモニターし、不整脈を検出することができるため、医師は迅速に介入し、心臓の有害事象を予防することができます。

心血管疾患、糖尿病、整形外科疾患などの慢性疾患の有病率が上昇していることが、植込み型医療機器の需要を押し上げています。世界保健機関（WHO）によると、低・中所得国を中心に世界で約4億2,200万人が糖尿病に罹患しており、年間150万人が死亡しており、患者数と有病率はここ数十年で着実に増加しています。

植込み型医療機器は、慢性疾患の管理、患者の運動能力の向上、生活の質の向上に重要な役割を果たしています。例えば、人工股関節や人工膝関節のような整形外科用インプラントは、変形性関節症の患者の関節機能を回復させ、痛みを和らげ、活動的なライフスタイルを維持できるようにします。さらに、パーキンソン病やてんかんといった神経疾患の治療にも、植込み型器具が使用されるようになってきています。2022～23年に発表されたパーキンソン財団の記事によると、米国では毎年9万人近くがパーキンソン病と診断されています。さらに、米国では約100万人がパーキンソン病と共存しています。神経刺激装置は、脳や神経の標的部位に電気インパルスを送り、震えや発作などの症状を軽減し、患者の日常機能と生活の質を向上させる。

植込み型医療機器の世界市場レポート区分

本レポートでは、2018～2030年の各サブセグメントにおける収益成長と最新動向の分析を予測しています。本レポートでは、Grand View Research, Inc.は世界の植込み型医療機器市場レポートを製品、生体材料、最終用途、地域に基づいてセグメント化しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 植込み型医療機器市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 補助市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 植込み型医療機器市場分析ツール
  • 業界分析-ポーターのファイブフォース分析
  • PESTEL分析
• 地域レベルでの価格分析
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第4章 植込み型医療機器市場： 製品別、推定・動向分析

• セグメントダッシュボード
• 植込み型医療機器市場：製品の変動分析、100万米ドル、2023年と2030年

第5章 植込み型医療機器市場：生体材料別、推定・動向分析

• セグメントダッシュボード
• 植込み型医療機器市場：生体材料の変動分析、100万米ドル、2023年と2030年

第6章 植込み型医療機器市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 植込み型医療機器市場：最終用途の変動分析、100万米ドル、2023年と2030年

第7章 植込み型医療機器市場：地域別、推定・動向分析、製品、生体材料、最終用途別

• 地域別市場シェア分析、2023年と2030年
• 地域別市場ダッシュボード
• 世界地域市場スナップショット
• 市場規模、予測動向分析、2018～2030年
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要企業の市場シェア分析、2023年
  • Medtronic
  • Abbott Laboratories
  • Johnson and Jhonson
  • Boston Scientific Corporation
  • Smith &Nephew plc
  • Stryker
  • Cochlear Limited
  • Integra LifeSciences
  • LivaNova PLC
  • Biotronik SE and Co. KG

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Leading Market Players Anticipated to Witness Highest Growth
• Table 4 Global Implantable Medical Devices Market, By Region, 2018 - 2030 (USD Million)
• Table 5 Global Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 6 Global Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 7 Global Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 8 North America Implantable Medical Devices Market, By Country, 2018 - 2030 (USD Million)
• Table 9 North America Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 10 North America Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 11 North America Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 12 U.S. Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 13 U.S. Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 14 U.S. Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 15 Canada Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 16 Canada Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 17 Canada Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 18 Mexico Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 19 Mexico Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 20 Mexico Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 21 Europe Implantable Medical Devices Market, By Country, 2018 - 2030 (USD Million)
• Table 22 Europe Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 23 Europe Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 24 Europe Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 25 UK Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 26 UK Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 27 UK Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 28 Germany Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 29 Germany Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 30 Germany Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 31 France Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 32 France Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 33 France Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 34 Italy Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 35 Italy Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 36 Italy Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 37 Spain Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 38 Spain Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 39 Spain Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 40 Denmark Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 41 Denmark Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 42 Denmark Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 43 Sweden Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 44 Sweden Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 45 Sweden Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 46 Norway Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 47 Norway Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 48 Norway Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Implantable Medical Devices Market, By Country, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 52 Asia Pacific Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 53 Japan Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 54 Japan Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 55 Japan Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 56 China Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 57 China Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 58 China Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 59 India Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 60 India Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 61 India Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 62 South Korea Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 63 South Korea Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 64 South Korea Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 65 Australia Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 66 Australia Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 67 Australia Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 68 Thailand Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 69 Thailand Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 70 Thailand Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 71 Latin America Implantable Medical Devices Market, By Country, 2018 - 2030 (USD Million)
• Table 72 Latin America Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 73 Latin America Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 74 Latin America Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 75 Brazil Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 76 Brazil Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 77 Brazil Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 78 Argentina Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 79 Argentina Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 80 Argentina Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 81 Middle East and Africa Implantable Medical Devices Market, By Country, 2018 - 2030 (USD Million)
• Table 82 Middle East and Africa Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 83 Middle East and Africa Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 84 Middle East & Africa Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 85 South Africa Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 86 South Africa Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 87 South Africa Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 90 Saudi Arabia Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 91 UAE Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 92 UAE Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 93 UAE Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)
• Table 94 Kuwait Implantable Medical Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 95 Kuwait Implantable Medical Devices Market, By Biomaterial, 2018 - 2030 (USD Million)
• Table 96 Kuwait Implantable Medical Devices Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Implantable Medical Devices market segment scope and defination
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2023)
• Fig. 10 Strategy framework
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 Market restraint relevance analysis (Current & future impact)
• Fig. 13 Penetration & growth prospect mapping
• Fig. 14 Porter's five forces analysis
• Fig. 15 PESTLE analysis
• Fig. 16 Implantable medical devices market: Product movement analysis
• Fig. 17 Implantable medical devices market: Product segment dashboard
• Fig. 18 Implantable medical devices market Product outlook: Key takeaways
• Fig. 19 Cardiovascular implantable medical devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Orthopedic implantable medical devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Opthalmology implantable medical devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Dental implantable medical devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Aesthetic implantable medical devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Neurology implantable medical devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Implantable medical devices market: Biomaterial movement analysis
• Fig. 26 Implantable medical devices market Biomaterial outlook: Key takeaways
• Fig. 27 Ceramic implantable medical devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Metallic implantable medical devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Polymers implantable medical devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Natural implantable medical devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Implantable medical devices market: End Use movement analysis
• Fig. 32 Implantable medical devices market End Use outlook: Key takeaways
• Fig. 33 Hospitals implantable medical devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Outpatient facilities implantable medical devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Specialty Specialty Clinics & Centers & centers implantable medical devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Regional outlook, 2023 & 2030
• Fig. 37 Regional market dashboard
• Fig. 38 Regional market place: Key takeaways
• Fig. 39 North America implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 40 U.S. implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 41 Canada implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 42 Mexico implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 43 Europe implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 44 UK implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 45 Germany implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 46 Spain implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 47 France implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 48 Italy implantable market, 2018 - 2030 (USD Million)
• Fig. 49 Denmark implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 50 Sweden implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 51 Norway implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 52 Asia Pacific implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 53 Japan implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 54 China implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 55 India implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 56 South Korea implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 57 Australia implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 58 Thailand implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 59 Latin America implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 60 Brazil implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 61 Argentina implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 62 MEA implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 63 South Africa implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 64 Saudi Arabia implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 65 UAE implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 66 Kuwait implantable medical devices market, 2018 - 2030 (USD Million)
• Fig. 67 Heat map analysis

Implantable Medical Devices Market Trends

The global implantable medical devices market size was estimated at USD 91.5 billion in 2023 and is projected to grow at a CAGR of 6.1 % from 2024 to 2030, owing to the advancements in technology, increasing prevalence of chronic diseases, and growing demand for minimally invasive surgical procedures. Advancements in surgical techniques, particularly minimally invasive procedures, have expanded the application of implantable medical devices. For instance, in January 2024, Accelus, a US-based medical technology company, introduced a modular-cortical system for spinal implant surgeries. The system allows surgeons to place screw shanks early and customize the construct. The system is available in open and cortical sets, catering to different surgical approaches.

Technological innovation plays a pivotal role in driving the market growth. Advances in materials science, miniaturization, biocompatibility, and sensor technology have revolutionized the design and functionality of implantable devices. For instance, the development of advanced biomaterials such as titanium alloys and bioresorbable polymers has enhanced the durability, biocompatibility, and integration of implants within the body. These materials reduce the risk of rejection, promote tissue regeneration, and improve long-term outcomes for patients.

Moreover, sensor technology and wireless connectivity have enabled implantable devices to collect real-time data on physiological parameters and transmit this information to healthcare providers remotely. This capability supports remote monitoring, early detection of complications, and timely intervention. For example, implantable cardiac monitors can continuously monitor heart rhythms and detect arrhythmias, allowing physicians to intervene promptly and prevent adverse cardiac events.

The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, and orthopedic conditions drives the demand for implantable medical devices. According to the World Health Organization (WHO), around 422 million people worldwide, primarily in low- and middle-income countries, are affected by diabetes, which causes 1.5 million deaths annually, with the number of cases and prevalence increasing steadily in recent decades.

Implantable medical devices play a critical role in managing chronic conditions, improving patient mobility, and enhancing quality of life. For instance, orthopedic implants such as hip and knee replacements restore joint function and alleviate pain in patients with osteoarthritis, enabling them to maintain an active lifestyle. In addition, implantable devices are increasingly used in the treatment of neurological disorders such as Parkinson's disease and epilepsy. According to Parkinson's Foundation article published in 2022-23, nearly 90,000 people in the U.S. are diagnosed yearly for Parkinson condition. Moreover, around 1 million people in the country are living with the condition. Neurostimulation devices deliver electrical impulses to targeted areas of the brain or nerves, reducing symptoms such as tremors or seizures and improving patients' daily functioning and quality of life.

Global Implantable Medical Devices Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global implantable medical devices market report based on product, biomaterial, end use, and regions:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Cardiovascular Implants
• Orthopedic Implants
• Ophthalmology Implants
• Dental Implants
• Aesthetic Implants
• Neurology Implants
• Biomaterial Outlook (Revenue, USD Million, 2018 - 2030)
• Ceramic
• Metallic
• Polymers
• Natural
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Outpatient Facilities
• Specialty Clinics & Centers
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America

U.S.

Canada

Mexico

• Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

• Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

• Latin America

Brazil

Argentina

• Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Biomaterial
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Outlook
  • 2.2.2. Biomaterial Outlook
  • 2.2.3. End Use Outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Implantable Medical Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing In Prevalence Of Chronic Diseases
    • 3.2.1.2. Technological Advancement
    • 3.2.1.3. Growing Demand For Minimally Invasive Surgical Procedures
  • 3.2.2. Market Restraint Analysis
• 3.3. Implantable Medical Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
• 3.4. Pricing Analysis, at Regional Level
  • 3.4.1. North America
  • 3.4.2. Europe
  • 3.4.3. Asia Pacific
  • 3.4.4. Latin America
  • 3.4.5. MEA

Chapter 4. Implantable Medical Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Implantable Medical Devices Market: Product Movement Analysis, USD Million, 2023 & 2030
  • 4.2.1. Cardiovascular Implants
    • 4.2.1.1. Cardiovascular Implants Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.2.2. Orthopedic Implants
    • 4.2.2.1. Orthopedic Implants Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.2.3. Ophthalmology Implants
    • 4.2.3.1. Ophthalmology Implants Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.2.4. Dental Implants
    • 4.2.4.1. Dental Implants Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.2.5. Aesthetic Implants
    • 4.2.5.1. Aesthetic Implants Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.2.6. Neurology Implants
    • 4.2.6.1. Neurology Implants Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Implantable Medical Devices Market: Biomaterial Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Implantable Medical Devices Market: Biomaterial Movement Analysis, USD Million, 2023 & 2030
  • 5.2.1. Ceramic
    • 5.2.1.1. Ceramic Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.2.2. Metallic
    • 5.2.2.1. Metallic Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.2.3. Polymers
    • 5.2.3.1. Polymers Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.2.4. Natural
    • 5.2.4.1. Natural Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Implantable Medical Devices Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Implantable Medical Devices Market: End Use Movement Analysis, USD Million, 2023 & 2030
  • 6.2.1. Hospitals
    • 6.2.1.1. Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.2.2. Outpatient Facilities
    • 6.2.2.1. Outpatient Facilities Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.2.3. Specialty Clinics & Centers & Centers
    • 6.2.3.1. Specialty Clinics & Centers & Centers Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Implantable Medical Devices Market: Regional Estimates & Trend Analysis, by Product, Biomaterial, and End Use

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework/ reimbursement structure
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework/ reimbursement structure
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework/ reimbursement structure
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework/ reimbursement structure
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework/ reimbursement structure
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework/ reimbursement structure
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework/ reimbursement structure
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Key company market share analysis, 2023
  • 8.3.2. Medtronic
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product Type benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Abbott Laboratories
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product Type benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Johnson and Jhonson
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product Type benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Boston Scientific Corporation
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product Type benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Smith & Nephew plc
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product Type benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Stryker
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product Type benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Cochlear Limited
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product Type benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Integra LifeSciences
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product Type benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. LivaNova PLC
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product Type benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Biotronik SE and Co. KG
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product Type benchmarking
    • 8.3.11.4. Strategic initiatives